Antineoplastic agent/Related Articles

From Citizendium, the Citizens' Compendium
Jump to: navigation, search
This article is developing and not approved.
Main Article
Talk
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
A list of Citizendium articles, and planned articles, about Antineoplastic agent.
See also changes related to Antineoplastic agent, or pages that link to Antineoplastic agent or to this page or whose text contains "Antineoplastic agent".


Parent topics

  • Cancer [r]: A generic term for a large group of diseases that can affect any part of the body; one defining feature is the rapid creation of abnormal cells that grow beyond their usual boundaries, and which can then invade adjoining parts of the body and spread to other organs. [e]
  • Immunology [r]: The study of all aspects of the immune system in all animals. [e]
  • Oncology [r]: The medical diagnosis and treatment of neoplasia, using pharmacologic, radiation, immunologic and surgical techniques; relevant formal subspecialties are medical oncology in internal medicine and radiation oncology in radiology; surgeons also may specialize in neoplasia [e]

Subtopics

Alkylating agents

Nitrogen mustards

Alkyl sulfonates

Ethylene imines

Nitrosoureas

Epoxides

Other alkylating agents

Antimetabolites

Folic acid analogues

Purine analogues

Pyrimidine analogues

Plant alkaloids and other natural products

Vinca alkaloids and analogues

ATC/DDD group L01CA.

Podophyllotoxin derivatives

Colchicine derivatives

Taxanes

Other plant alkaloids and natural products

Cytotoxic antibiotics and related substances

Actinomycines

Anthracyclines and related substances

Other cytotoxic antibiotics

Other antineoplastic agents

ATC/DDD group L01X.

Platinum compounds

ATC/DDD group L01XA.

Methylhydrazines

ATC/DDD group L01XB.

Monoclonal antibodies

ATC/DDD group L01XC. Examples include:

Anti-EGRF
Anti-EpCAM
Anti-ERBB2
Anti-CD3 and anti-EpCAM
  • Catumaxomab [r]: Add brief definition or description Is a monoclonal antibody against CD3 (Entrez protein)and EpCAM (Entrez protein). "Extracorporeal PBMNC coating with catumaxomab may be an option to control intravascular cytokine release induced by therapeutic antibodies".[11]
Anti-MS4A1 (CD20 antigen)
  • Rituximab [r]: Chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells, and used in the treatment of many lymphomas, and leukaemias. [e] is a "genetically engineered anti-CD20 (Entrez protein) antibody for the treatment of B-cell lymphoma".[12]
Anti-SIGLEC3 (CD33)
Anti-CD52
Anti-VEGF

Sensitizers used in photodynamic/radiation therapy

Protein kinase inhibitors

Other related topics